HEADER IMMUNE SYSTEM 07-JUL-09 3I6K TITLE NEWLY IDENTIFIED EPITOPE FROM SARS-COV MEMBRANE PROTEIN COMPLEXED WITH TITLE 2 HLA-A*0201 COMPND MOL_ID: 1; COMPND 2 MOLECULE: HLA CLASS I HISTOCOMPATIBILITY ANTIGEN, A-2 ALPHA CHAIN; COMPND 3 CHAIN: A, E; COMPND 4 FRAGMENT: ALPHA 1-3 REGIONS, UNP RESIDUES 25-299; COMPND 5 SYNONYM: HLA-A*0201, MHC CLASS I ANTIGEN A*2; COMPND 6 ENGINEERED: YES; COMPND 7 MOL_ID: 2; COMPND 8 MOLECULE: BETA-2-MICROGLOBULIN; COMPND 9 CHAIN: B, F; COMPND 10 SYNONYM: BETA-2-MICROGLOBULIN FORM PI 5.3; COMPND 11 ENGINEERED: YES; COMPND 12 MOL_ID: 3; COMPND 13 MOLECULE: MEMBRANE GLYCOPROTEIN PEPTIDE; COMPND 14 CHAIN: C, G; COMPND 15 FRAGMENT: UNP RESIDUE 60-69; COMPND 16 SYNONYM: PEPTIDE MD3; COMPND 17 ENGINEERED: YES SOURCE MOL_ID: 1; SOURCE 2 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 3 ORGANISM_COMMON: HUMAN; SOURCE 4 ORGANISM_TAXID: 9606; SOURCE 5 GENE: HLA-A, HLA-A*0201 ALLELE, HLAA, HOMO SAPIENS MHC CLASS I SOURCE 6 ANTIGEN (HLA-A); SOURCE 7 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 8 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 9 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 10 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 11 EXPRESSION_SYSTEM_PLASMID: PET28B; SOURCE 12 MOL_ID: 2; SOURCE 13 ORGANISM_SCIENTIFIC: HOMO SAPIENS; SOURCE 14 ORGANISM_COMMON: HUMAN; SOURCE 15 ORGANISM_TAXID: 9606; SOURCE 16 GENE: B2M, BETA-2-MICROGLOBULIN, CDABP0092, HDCMA22P; SOURCE 17 EXPRESSION_SYSTEM: ESCHERICHIA COLI; SOURCE 18 EXPRESSION_SYSTEM_TAXID: 469008; SOURCE 19 EXPRESSION_SYSTEM_STRAIN: BL21 (DE3); SOURCE 20 EXPRESSION_SYSTEM_VECTOR_TYPE: PLASMID; SOURCE 21 EXPRESSION_SYSTEM_PLASMID: PGMT7; SOURCE 22 MOL_ID: 3; SOURCE 23 SYNTHETIC: YES; SOURCE 24 ORGANISM_SCIENTIFIC: SARS CORONAVIRUS TJF; SOURCE 25 ORGANISM_TAXID: 284672; SOURCE 26 OTHER_DETAILS: CHEMICAL SYNTHESIZED KEYWDS HLA-A2, SARS-COV, MEMBRANE GLYCOPROTEIN, DISULFIDE BOND, KEYWDS 2 GLYCOPROTEIN, HOST-VIRUS INTERACTION, IMMUNE RESPONSE, MEMBRANE, MHC KEYWDS 3 I, PHOSPHOPROTEIN, TRANSMEMBRANE, DISEASE MUTATION, GLYCATION, KEYWDS 4 IMMUNOGLOBULIN DOMAIN, PYRROLIDONE CARBOXYLIC ACID, SECRETED, KEYWDS 5 ENVELOPE PROTEIN, GOLGI APPARATUS, VIRAL MATRIX PROTEIN, VIRION, KEYWDS 6 IMMUNE SYSTEM EXPDTA X-RAY DIFFRACTION AUTHOR J.LIU,Y.SUN,J.QI,F.CHU,H.WU,F.GAO,T.LI,J.YAN,G.F.GAO REVDAT 4 30-OCT-24 3I6K 1 REMARK REVDAT 3 01-NOV-23 3I6K 1 SEQADV REVDAT 2 03-NOV-10 3I6K 1 JRNL REVDAT 1 16-JUN-10 3I6K 0 JRNL AUTH J.LIU,Y.SUN,J.QI,F.CHU,H.WU,F.GAO,T.LI,J.YAN,G.F.GAO JRNL TITL THE MEMBRANE PROTEIN OF SEVERE ACUTE RESPIRATORY SYNDROME JRNL TITL 2 CORONAVIRUS ACTS AS A DOMINANT IMMUNOGEN REVEALED BY A JRNL TITL 3 CLUSTERING REGION OF NOVEL FUNCTIONALLY AND STRUCTURALLY JRNL TITL 4 DEFINED CYTOTOXIC T-LYMPHOCYTE EPITOPES JRNL REF J INFECT DIS V. 202 1171 2010 JRNL REFN ESSN 1537-6613 JRNL PMID 20831383 JRNL DOI 10.1086/656315 REMARK 2 REMARK 2 RESOLUTION. 2.80 ANGSTROMS. REMARK 3 REMARK 3 REFINEMENT. REMARK 3 PROGRAM : PHENIX (PHENIX.REFINE) REMARK 3 AUTHORS : PAUL ADAMS,PAVEL AFONINE,VINCENT CHEN,IAN REMARK 3 : DAVIS,KRESHNA GOPAL,RALF GROSSE-KUNSTLEVE, REMARK 3 : LI-WEI HUNG,ROBERT IMMORMINO,TOM IOERGER, REMARK 3 : AIRLIE MCCOY,ERIK MCKEE,NIGEL MORIARTY, REMARK 3 : REETAL PAI,RANDY READ,JANE RICHARDSON, REMARK 3 : DAVID RICHARDSON,TOD ROMO,JIM SACCHETTINI, REMARK 3 : NICHOLAS SAUTER,JACOB SMITH,LAURENT REMARK 3 : STORONI,TOM TERWILLIGER,PETER ZWART REMARK 3 REMARK 3 REFINEMENT TARGET : ML REMARK 3 REMARK 3 DATA USED IN REFINEMENT. REMARK 3 RESOLUTION RANGE HIGH (ANGSTROMS) : 2.80 REMARK 3 RESOLUTION RANGE LOW (ANGSTROMS) : 32.21 REMARK 3 MIN(FOBS/SIGMA_FOBS) : 0.110 REMARK 3 COMPLETENESS FOR RANGE (%) : 96.0 REMARK 3 NUMBER OF REFLECTIONS : 23322 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT. REMARK 3 R VALUE (WORKING + TEST SET) : 0.200 REMARK 3 R VALUE (WORKING SET) : 0.198 REMARK 3 FREE R VALUE : 0.244 REMARK 3 FREE R VALUE TEST SET SIZE (%) : 5.080 REMARK 3 FREE R VALUE TEST SET COUNT : 1184 REMARK 3 REMARK 3 FIT TO DATA USED IN REFINEMENT (IN BINS). REMARK 3 BIN RESOLUTION RANGE COMPL. NWORK NFREE RWORK RFREE REMARK 3 1 32.2111 - 5.5915 0.98 2998 137 0.1994 0.2410 REMARK 3 2 5.5915 - 4.4419 0.98 2856 150 0.1507 0.1850 REMARK 3 3 4.4419 - 3.8815 0.97 2776 170 0.1647 0.1832 REMARK 3 4 3.8815 - 3.5271 0.98 2819 147 0.1778 0.2298 REMARK 3 5 3.5271 - 3.2745 0.96 2690 161 0.2042 0.2438 REMARK 3 6 3.2745 - 3.0816 0.96 2716 152 0.2168 0.2961 REMARK 3 7 3.0816 - 2.9274 0.93 2642 130 0.2326 0.3140 REMARK 3 8 2.9274 - 2.8001 0.92 2641 137 0.2271 0.2927 REMARK 3 REMARK 3 BULK SOLVENT MODELLING. REMARK 3 METHOD USED : FLAT BULK SOLVENT MODEL REMARK 3 SOLVENT RADIUS : 1.11 REMARK 3 SHRINKAGE RADIUS : 0.90 REMARK 3 K_SOL : 0.33 REMARK 3 B_SOL : 19.51 REMARK 3 REMARK 3 ERROR ESTIMATES. REMARK 3 COORDINATE ERROR (MAXIMUM-LIKELIHOOD BASED) : 0.290 REMARK 3 PHASE ERROR (DEGREES, MAXIMUM-LIKELIHOOD BASED) : 22.230 REMARK 3 REMARK 3 B VALUES. REMARK 3 FROM WILSON PLOT (A**2) : 35.60 REMARK 3 MEAN B VALUE (OVERALL, A**2) : 35.60 REMARK 3 OVERALL ANISOTROPIC B VALUE. REMARK 3 B11 (A**2) : -12.32300 REMARK 3 B22 (A**2) : -16.47900 REMARK 3 B33 (A**2) : -11.16900 REMARK 3 B12 (A**2) : 0.00000 REMARK 3 B13 (A**2) : 0.00000 REMARK 3 B23 (A**2) : 0.00000 REMARK 3 REMARK 3 TWINNING INFORMATION. REMARK 3 FRACTION: NULL REMARK 3 OPERATOR: NULL REMARK 3 REMARK 3 DEVIATIONS FROM IDEAL VALUES. REMARK 3 RMSD COUNT REMARK 3 BOND : 0.003 6451 REMARK 3 ANGLE : 0.656 8740 REMARK 3 CHIRALITY : 0.049 896 REMARK 3 PLANARITY : 0.002 1138 REMARK 3 DIHEDRAL : 16.878 2302 REMARK 3 REMARK 3 TLS DETAILS REMARK 3 NUMBER OF TLS GROUPS : NULL REMARK 3 REMARK 3 NCS DETAILS REMARK 3 NUMBER OF NCS GROUPS : NULL REMARK 3 REMARK 3 OTHER REFINEMENT REMARKS: NULL REMARK 4 REMARK 4 3I6K COMPLIES WITH FORMAT V. 3.30, 13-JUL-11 REMARK 100 REMARK 100 THIS ENTRY HAS BEEN PROCESSED BY PDBJ ON 09-JUL-09. REMARK 100 THE DEPOSITION ID IS D_1000054027. REMARK 200 REMARK 200 EXPERIMENTAL DETAILS REMARK 200 EXPERIMENT TYPE : X-RAY DIFFRACTION REMARK 200 DATE OF DATA COLLECTION : 14-SEP-08 REMARK 200 TEMPERATURE (KELVIN) : 100 REMARK 200 PH : 5.5 REMARK 200 NUMBER OF CRYSTALS USED : 1 REMARK 200 REMARK 200 SYNCHROTRON (Y/N) : N REMARK 200 RADIATION SOURCE : ROTATING ANODE REMARK 200 BEAMLINE : NULL REMARK 200 X-RAY GENERATOR MODEL : RIGAKU MICROMAX-007 REMARK 200 MONOCHROMATIC OR LAUE (M/L) : M REMARK 200 WAVELENGTH OR RANGE (A) : 1.54178 REMARK 200 MONOCHROMATOR : NULL REMARK 200 OPTICS : NULL REMARK 200 REMARK 200 DETECTOR TYPE : IMAGE PLATE REMARK 200 DETECTOR MANUFACTURER : RIGAKU RAXIS VII REMARK 200 INTENSITY-INTEGRATION SOFTWARE : HKL-2000 REMARK 200 DATA SCALING SOFTWARE : HKL-2000 REMARK 200 REMARK 200 NUMBER OF UNIQUE REFLECTIONS : 25460 REMARK 200 RESOLUTION RANGE HIGH (A) : 2.750 REMARK 200 RESOLUTION RANGE LOW (A) : 32.209 REMARK 200 REJECTION CRITERIA (SIGMA(I)) : -3.000 REMARK 200 REMARK 200 OVERALL. REMARK 200 COMPLETENESS FOR RANGE (%) : 99.5 REMARK 200 DATA REDUNDANCY : 6.800 REMARK 200 R MERGE (I) : 0.17000 REMARK 200 R SYM (I) : 0.17000 REMARK 200 <I/SIGMA(I)> FOR THE DATA SET : 15.8360 REMARK 200 REMARK 200 IN THE HIGHEST RESOLUTION SHELL. REMARK 200 HIGHEST RESOLUTION SHELL, RANGE HIGH (A) : 2.75 REMARK 200 HIGHEST RESOLUTION SHELL, RANGE LOW (A) : 2.85 REMARK 200 COMPLETENESS FOR SHELL (%) : 98.8 REMARK 200 DATA REDUNDANCY IN SHELL : 6.50 REMARK 200 R MERGE FOR SHELL (I) : 0.47500 REMARK 200 R SYM FOR SHELL (I) : NULL REMARK 200 <I/SIGMA(I)> FOR SHELL : 4.821 REMARK 200 REMARK 200 DIFFRACTION PROTOCOL: SINGLE WAVELENGTH REMARK 200 METHOD USED TO DETERMINE THE STRUCTURE: MOLECULAR REPLACEMENT REMARK 200 SOFTWARE USED: AMORE REMARK 200 STARTING MODEL: PDB ENTRY 1JF1 REMARK 200 REMARK 200 REMARK: NULL REMARK 280 REMARK 280 CRYSTAL REMARK 280 SOLVENT CONTENT, VS (%): 53.93 REMARK 280 MATTHEWS COEFFICIENT, VM (ANGSTROMS**3/DA): 2.67 REMARK 280 REMARK 280 CRYSTALLIZATION CONDITIONS: 0.1M BIS-TRIS PH 5.5, 10% W/V REMARK 280 POLYETHYLENE GLYCOL 3350, VAPOR DIFFUSION, HANGING DROP, REMARK 280 TEMPERATURE 277K REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY REMARK 290 SYMMETRY OPERATORS FOR SPACE GROUP: P 21 21 21 REMARK 290 REMARK 290 SYMOP SYMMETRY REMARK 290 NNNMMM OPERATOR REMARK 290 1555 X,Y,Z REMARK 290 2555 -X+1/2,-Y,Z+1/2 REMARK 290 3555 -X,Y+1/2,-Z+1/2 REMARK 290 4555 X+1/2,-Y+1/2,-Z REMARK 290 REMARK 290 WHERE NNN -> OPERATOR NUMBER REMARK 290 MMM -> TRANSLATION VECTOR REMARK 290 REMARK 290 CRYSTALLOGRAPHIC SYMMETRY TRANSFORMATIONS REMARK 290 THE FOLLOWING TRANSFORMATIONS OPERATE ON THE ATOM/HETATM REMARK 290 RECORDS IN THIS ENTRY TO PRODUCE CRYSTALLOGRAPHICALLY REMARK 290 RELATED MOLECULES. REMARK 290 SMTRY1 1 1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 1 0.000000 1.000000 0.000000 0.00000 REMARK 290 SMTRY3 1 0.000000 0.000000 1.000000 0.00000 REMARK 290 SMTRY1 2 -1.000000 0.000000 0.000000 32.77000 REMARK 290 SMTRY2 2 0.000000 -1.000000 0.000000 0.00000 REMARK 290 SMTRY3 2 0.000000 0.000000 1.000000 67.48750 REMARK 290 SMTRY1 3 -1.000000 0.000000 0.000000 0.00000 REMARK 290 SMTRY2 3 0.000000 1.000000 0.000000 54.01400 REMARK 290 SMTRY3 3 0.000000 0.000000 -1.000000 67.48750 REMARK 290 SMTRY1 4 1.000000 0.000000 0.000000 32.77000 REMARK 290 SMTRY2 4 0.000000 -1.000000 0.000000 54.01400 REMARK 290 SMTRY3 4 0.000000 0.000000 -1.000000 0.00000 REMARK 290 REMARK 290 REMARK: NULL REMARK 300 REMARK 300 BIOMOLECULE: 1, 2 REMARK 300 SEE REMARK 350 FOR THE AUTHOR PROVIDED AND/OR PROGRAM REMARK 300 GENERATED ASSEMBLY INFORMATION FOR THE STRUCTURE IN REMARK 300 THIS ENTRY. THE REMARK MAY ALSO PROVIDE INFORMATION ON REMARK 300 BURIED SURFACE AREA. REMARK 350 REMARK 350 COORDINATES FOR A COMPLETE MULTIMER REPRESENTING THE KNOWN REMARK 350 BIOLOGICALLY SIGNIFICANT OLIGOMERIZATION STATE OF THE REMARK 350 MOLECULE CAN BE GENERATED BY APPLYING BIOMT TRANSFORMATIONS REMARK 350 GIVEN BELOW. BOTH NON-CRYSTALLOGRAPHIC AND REMARK 350 CRYSTALLOGRAPHIC OPERATIONS ARE GIVEN. REMARK 350 REMARK 350 BIOMOLECULE: 1 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4340 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 18670 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -20.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: A, B, C REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 350 REMARK 350 BIOMOLECULE: 2 REMARK 350 AUTHOR DETERMINED BIOLOGICAL UNIT: TRIMERIC REMARK 350 SOFTWARE DETERMINED QUATERNARY STRUCTURE: TRIMERIC REMARK 350 SOFTWARE USED: PISA REMARK 350 TOTAL BURIED SURFACE AREA: 4200 ANGSTROM**2 REMARK 350 SURFACE AREA OF THE COMPLEX: 19050 ANGSTROM**2 REMARK 350 CHANGE IN SOLVENT FREE ENERGY: -22.0 KCAL/MOL REMARK 350 APPLY THE FOLLOWING TO CHAINS: E, F, G REMARK 350 BIOMT1 1 1.000000 0.000000 0.000000 0.00000 REMARK 350 BIOMT2 1 0.000000 1.000000 0.000000 0.00000 REMARK 350 BIOMT3 1 0.000000 0.000000 1.000000 0.00000 REMARK 465 REMARK 465 MISSING RESIDUES REMARK 465 THE FOLLOWING RESIDUES WERE NOT LOCATED IN THE REMARK 465 EXPERIMENT. (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN REMARK 465 IDENTIFIER; SSSEQ=SEQUENCE NUMBER; I=INSERTION CODE.) REMARK 465 REMARK 465 M RES C SSSEQI REMARK 465 GLN A 226 REMARK 465 ASP A 227 REMARK 465 GLN E 226 REMARK 465 ASP E 227 REMARK 470 REMARK 470 MISSING ATOM REMARK 470 THE FOLLOWING RESIDUES HAVE MISSING ATOMS (M=MODEL NUMBER; REMARK 470 RES=RESIDUE NAME; C=CHAIN IDENTIFIER; SSEQ=SEQUENCE NUMBER; REMARK 470 I=INSERTION CODE): REMARK 470 M RES CSSEQI ATOMS REMARK 470 VAL A 247 CG1 CG2 REMARK 470 VAL E 247 CG1 CG2 REMARK 500 REMARK 500 GEOMETRY AND STEREOCHEMISTRY REMARK 500 SUBTOPIC: TORSION ANGLES REMARK 500 REMARK 500 TORSION ANGLES OUTSIDE THE EXPECTED RAMACHANDRAN REGIONS: REMARK 500 (M=MODEL NUMBER; RES=RESIDUE NAME; C=CHAIN IDENTIFIER; REMARK 500 SSEQ=SEQUENCE NUMBER; I=INSERTION CODE). REMARK 500 REMARK 500 STANDARD TABLE: REMARK 500 FORMAT:(10X,I3,1X,A3,1X,A1,I4,A1,4X,F7.2,3X,F7.2) REMARK 500 REMARK 500 EXPECTED VALUES: GJ KLEYWEGT AND TA JONES (1996). PHI/PSI- REMARK 500 CHOLOGY: RAMACHANDRAN REVISITED. STRUCTURE 4, 1395 - 1400 REMARK 500 REMARK 500 M RES CSSEQI PSI PHI REMARK 500 ASP A 29 -128.21 60.85 REMARK 500 GLU A 89 42.70 -83.19 REMARK 500 ARG A 111 147.64 -172.49 REMARK 500 TYR A 123 -70.37 -119.25 REMARK 500 THR A 178 -64.27 -91.48 REMARK 500 GLN A 180 38.12 -88.79 REMARK 500 PRO A 210 -168.24 -74.71 REMARK 500 ASP A 223 157.66 -47.88 REMARK 500 LYS A 243 139.26 -176.47 REMARK 500 HIS B 31 132.54 -172.41 REMARK 500 PRO B 32 -169.00 -75.44 REMARK 500 TRP B 60 2.29 84.79 REMARK 500 ASP E 29 -123.27 50.35 REMARK 500 ASN E 86 60.42 38.22 REMARK 500 GLN E 180 36.64 -91.37 REMARK 500 HIS E 188 154.58 178.91 REMARK 500 SER E 195 -158.45 -162.94 REMARK 500 PRO E 210 -166.40 -74.88 REMARK 500 LYS E 243 140.13 -174.08 REMARK 500 ASN F 21 -169.33 -161.00 REMARK 500 TRP F 60 -2.50 72.16 REMARK 500 LYS F 75 54.98 -147.31 REMARK 500 REMARK 500 REMARK: NULL DBREF 3I6K A 1 275 UNP P01892 1A02_HUMAN 25 299 DBREF 3I6K B 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 3I6K C 0 9 UNP Q692E0 Q692E0_CVHSA 60 69 DBREF 3I6K E 1 275 UNP P01892 1A02_HUMAN 25 299 DBREF 3I6K F 1 99 UNP P61769 B2MG_HUMAN 21 119 DBREF 3I6K G 0 9 UNP Q692E0 Q692E0_CVHSA 60 69 SEQADV 3I6K MET B 0 UNP P61769 INITIATING METHIONINE SEQADV 3I6K MET F 0 UNP P61769 INITIATING METHIONINE SEQRES 1 A 275 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 A 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 A 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 A 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 A 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 A 275 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 A 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 A 275 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 A 275 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 A 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 A 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 A 275 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 A 275 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 A 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 A 275 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 A 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 A 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 A 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 A 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 A 275 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 A 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 A 275 TRP GLU SEQRES 1 B 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 B 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 B 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 B 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 B 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 B 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 B 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 B 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 C 10 THR LEU ALA CYS PHE VAL LEU ALA ALA VAL SEQRES 1 E 275 GLY SER HIS SER MET ARG TYR PHE PHE THR SER VAL SER SEQRES 2 E 275 ARG PRO GLY ARG GLY GLU PRO ARG PHE ILE ALA VAL GLY SEQRES 3 E 275 TYR VAL ASP ASP THR GLN PHE VAL ARG PHE ASP SER ASP SEQRES 4 E 275 ALA ALA SER GLN ARG MET GLU PRO ARG ALA PRO TRP ILE SEQRES 5 E 275 GLU GLN GLU GLY PRO GLU TYR TRP ASP GLY GLU THR ARG SEQRES 6 E 275 LYS VAL LYS ALA HIS SER GLN THR HIS ARG VAL ASP LEU SEQRES 7 E 275 GLY THR LEU ARG GLY TYR TYR ASN GLN SER GLU ALA GLY SEQRES 8 E 275 SER HIS THR VAL GLN ARG MET TYR GLY CYS ASP VAL GLY SEQRES 9 E 275 SER ASP TRP ARG PHE LEU ARG GLY TYR HIS GLN TYR ALA SEQRES 10 E 275 TYR ASP GLY LYS ASP TYR ILE ALA LEU LYS GLU ASP LEU SEQRES 11 E 275 ARG SER TRP THR ALA ALA ASP MET ALA ALA GLN THR THR SEQRES 12 E 275 LYS HIS LYS TRP GLU ALA ALA HIS VAL ALA GLU GLN LEU SEQRES 13 E 275 ARG ALA TYR LEU GLU GLY THR CYS VAL GLU TRP LEU ARG SEQRES 14 E 275 ARG TYR LEU GLU ASN GLY LYS GLU THR LEU GLN ARG THR SEQRES 15 E 275 ASP ALA PRO LYS THR HIS MET THR HIS HIS ALA VAL SER SEQRES 16 E 275 ASP HIS GLU ALA THR LEU ARG CYS TRP ALA LEU SER PHE SEQRES 17 E 275 TYR PRO ALA GLU ILE THR LEU THR TRP GLN ARG ASP GLY SEQRES 18 E 275 GLU ASP GLN THR GLN ASP THR GLU LEU VAL GLU THR ARG SEQRES 19 E 275 PRO ALA GLY ASP GLY THR PHE GLN LYS TRP ALA ALA VAL SEQRES 20 E 275 VAL VAL PRO SER GLY GLN GLU GLN ARG TYR THR CYS HIS SEQRES 21 E 275 VAL GLN HIS GLU GLY LEU PRO LYS PRO LEU THR LEU ARG SEQRES 22 E 275 TRP GLU SEQRES 1 F 100 MET ILE GLN ARG THR PRO LYS ILE GLN VAL TYR SER ARG SEQRES 2 F 100 HIS PRO ALA GLU ASN GLY LYS SER ASN PHE LEU ASN CYS SEQRES 3 F 100 TYR VAL SER GLY PHE HIS PRO SER ASP ILE GLU VAL ASP SEQRES 4 F 100 LEU LEU LYS ASN GLY GLU ARG ILE GLU LYS VAL GLU HIS SEQRES 5 F 100 SER ASP LEU SER PHE SER LYS ASP TRP SER PHE TYR LEU SEQRES 6 F 100 LEU TYR TYR THR GLU PHE THR PRO THR GLU LYS ASP GLU SEQRES 7 F 100 TYR ALA CYS ARG VAL ASN HIS VAL THR LEU SER GLN PRO SEQRES 8 F 100 LYS ILE VAL LYS TRP ASP ARG ASP MET SEQRES 1 G 10 THR LEU ALA CYS PHE VAL LEU ALA ALA VAL FORMUL 7 HOH *183(H2 O) HELIX 1 1 ALA A 49 GLU A 53 5 5 HELIX 2 2 GLY A 56 TYR A 85 1 30 HELIX 3 3 MET A 138 ALA A 150 1 13 HELIX 4 4 HIS A 151 GLY A 162 1 12 HELIX 5 5 GLY A 162 GLY A 175 1 14 HELIX 6 6 GLY A 175 GLN A 180 1 6 HELIX 7 7 ALA E 49 GLU E 53 5 5 HELIX 8 8 GLY E 56 TYR E 85 1 30 HELIX 9 9 ALA E 140 ALA E 150 1 11 HELIX 10 10 HIS E 151 GLY E 162 1 12 HELIX 11 11 GLY E 162 GLY E 175 1 14 HELIX 12 12 GLY E 175 GLN E 180 1 6 HELIX 13 13 GLN E 253 GLN E 255 5 3 SHEET 1 A 8 GLU A 46 PRO A 47 0 SHEET 2 A 8 THR A 31 ASP A 37 -1 N ARG A 35 O GLU A 46 SHEET 3 A 8 ARG A 21 VAL A 28 -1 N VAL A 28 O THR A 31 SHEET 4 A 8 HIS A 3 VAL A 12 -1 N ARG A 6 O TYR A 27 SHEET 5 A 8 THR A 94 VAL A 103 -1 O ARG A 97 N PHE A 9 SHEET 6 A 8 PHE A 109 TYR A 118 -1 O LEU A 110 N ASP A 102 SHEET 7 A 8 LYS A 121 LEU A 126 -1 O TYR A 123 N TYR A 116 SHEET 8 A 8 TRP A 133 ALA A 135 -1 O THR A 134 N ALA A 125 SHEET 1 B 4 LYS A 186 HIS A 192 0 SHEET 2 B 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 B 4 PHE A 241 PRO A 250 -1 O ALA A 245 N CYS A 203 SHEET 4 B 4 GLU A 229 LEU A 230 -1 N GLU A 229 O ALA A 246 SHEET 1 C 4 LYS A 186 HIS A 192 0 SHEET 2 C 4 GLU A 198 PHE A 208 -1 O THR A 200 N HIS A 192 SHEET 3 C 4 PHE A 241 PRO A 250 -1 O ALA A 245 N CYS A 203 SHEET 4 C 4 ARG A 234 PRO A 235 -1 N ARG A 234 O GLN A 242 SHEET 1 D 3 THR A 214 ARG A 219 0 SHEET 2 D 3 TYR A 257 GLN A 262 -1 O HIS A 260 N THR A 216 SHEET 3 D 3 LEU A 270 ARG A 273 -1 O LEU A 272 N CYS A 259 SHEET 1 E 4 LYS B 6 SER B 11 0 SHEET 2 E 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 E 4 PHE B 62 PHE B 70 -1 O PHE B 70 N ASN B 21 SHEET 4 E 4 GLU B 50 HIS B 51 -1 N GLU B 50 O TYR B 67 SHEET 1 F 4 LYS B 6 SER B 11 0 SHEET 2 F 4 ASN B 21 PHE B 30 -1 O ASN B 24 N TYR B 10 SHEET 3 F 4 PHE B 62 PHE B 70 -1 O PHE B 70 N ASN B 21 SHEET 4 F 4 SER B 55 PHE B 56 -1 N SER B 55 O TYR B 63 SHEET 1 G 4 GLU B 44 ARG B 45 0 SHEET 2 G 4 GLU B 36 LYS B 41 -1 N LYS B 41 O GLU B 44 SHEET 3 G 4 TYR B 78 ASN B 83 -1 O ARG B 81 N ASP B 38 SHEET 4 G 4 LYS B 91 LYS B 94 -1 O VAL B 93 N CYS B 80 SHEET 1 H 8 GLU E 46 PRO E 47 0 SHEET 2 H 8 THR E 31 ASP E 37 -1 N ARG E 35 O GLU E 46 SHEET 3 H 8 ARG E 21 VAL E 28 -1 N VAL E 28 O THR E 31 SHEET 4 H 8 HIS E 3 VAL E 12 -1 N THR E 10 O ILE E 23 SHEET 5 H 8 THR E 94 VAL E 103 -1 O ARG E 97 N PHE E 9 SHEET 6 H 8 PHE E 109 TYR E 118 -1 O GLN E 115 N MET E 98 SHEET 7 H 8 LYS E 121 LEU E 126 -1 O TYR E 123 N TYR E 116 SHEET 8 H 8 TRP E 133 ALA E 135 -1 O THR E 134 N ALA E 125 SHEET 1 I 4 LYS E 186 ALA E 193 0 SHEET 2 I 4 GLU E 198 PHE E 208 -1 O LEU E 206 N LYS E 186 SHEET 3 I 4 PHE E 241 PRO E 250 -1 O VAL E 249 N ALA E 199 SHEET 4 I 4 GLU E 229 LEU E 230 -1 N GLU E 229 O ALA E 246 SHEET 1 J 4 LYS E 186 ALA E 193 0 SHEET 2 J 4 GLU E 198 PHE E 208 -1 O LEU E 206 N LYS E 186 SHEET 3 J 4 PHE E 241 PRO E 250 -1 O VAL E 249 N ALA E 199 SHEET 4 J 4 ARG E 234 PRO E 235 -1 N ARG E 234 O GLN E 242 SHEET 1 K 4 GLU E 222 ASP E 223 0 SHEET 2 K 4 THR E 214 ARG E 219 -1 N ARG E 219 O GLU E 222 SHEET 3 K 4 TYR E 257 GLN E 262 -1 O HIS E 260 N THR E 216 SHEET 4 K 4 LEU E 270 LEU E 272 -1 O LEU E 272 N CYS E 259 SHEET 1 L 4 LYS F 6 SER F 11 0 SHEET 2 L 4 ASN F 21 PHE F 30 -1 O ASN F 24 N TYR F 10 SHEET 3 L 4 PHE F 62 PHE F 70 -1 O LEU F 64 N VAL F 27 SHEET 4 L 4 GLU F 50 HIS F 51 -1 N GLU F 50 O TYR F 67 SHEET 1 M 4 LYS F 6 SER F 11 0 SHEET 2 M 4 ASN F 21 PHE F 30 -1 O ASN F 24 N TYR F 10 SHEET 3 M 4 PHE F 62 PHE F 70 -1 O LEU F 64 N VAL F 27 SHEET 4 M 4 SER F 55 PHE F 56 -1 N SER F 55 O TYR F 63 SHEET 1 N 3 GLU F 36 LYS F 41 0 SHEET 2 N 3 TYR F 78 ASN F 83 -1 O ALA F 79 N LEU F 40 SHEET 3 N 3 LYS F 91 LYS F 94 -1 O LYS F 91 N VAL F 82 SSBOND 1 CYS A 101 CYS A 164 1555 1555 2.04 SSBOND 2 CYS A 203 CYS A 259 1555 1555 2.03 SSBOND 3 CYS B 25 CYS B 80 1555 1555 2.03 SSBOND 4 CYS C 3 CYS G 3 1555 1455 2.02 SSBOND 5 CYS E 101 CYS E 164 1555 1555 2.04 SSBOND 6 CYS E 203 CYS E 259 1555 1555 2.03 SSBOND 7 CYS F 25 CYS F 80 1555 1555 2.03 CISPEP 1 TYR A 209 PRO A 210 0 1.60 CISPEP 2 HIS B 31 PRO B 32 0 2.34 CISPEP 3 GLU B 74 LYS B 75 0 8.48 CISPEP 4 TYR E 209 PRO E 210 0 2.72 CISPEP 5 HIS F 31 PRO F 32 0 0.90 CRYST1 65.540 108.028 134.975 90.00 90.00 90.00 P 21 21 21 8 ORIGX1 1.000000 0.000000 0.000000 0.00000 ORIGX2 0.000000 1.000000 0.000000 0.00000 ORIGX3 0.000000 0.000000 1.000000 0.00000 SCALE1 0.015258 0.000000 0.000000 0.00000 SCALE2 0.000000 0.009257 0.000000 0.00000 SCALE3 0.000000 0.000000 0.007409 0.00000